Connect Sign In
Specimens are readied for phosphorylated tau 217 (pTau 217) testing in ARUP’s Electrophoresis and Manual Endocrinology Laboratory. ARUP’s blood-based pTau 217 test assists in identifying whether cognitive decline symptoms are related to Alzheimer’s disease pathology.
Providing excellent patient care and improving continuously are core values at ARUP Laboratories. In 2025, our medical directors and scientists made significant contributions to laboratory medicine as primary authors and coauthors of more than 130 peer-reviewed articles in academic journals. They also presented at more than 100 national and international medical conferences, underscoring ARUP’s commitment to research, education, and innovation.
Research published in 2025 showcased the breadth of ARUP’s expertise, with work spanning genomic medicine and rare-disease discovery, advancements in molecular and cytogenetic diagnostics, innovations in hematopathology and transfusion medicine, and contributions to infectious disease testing, microbiology, and artificial intelligence. A full list of ARUP’s 2025 journal articles and conference materials is available on the ARUP Research page.
As a nonprofit enterprise of the University of Utah and its Department of Pathology, ARUP has long prioritized the dissemination of knowledge to advance diagnostics and improve patient outcomes.
“Presentations at conferences and publication of ARUP’s clinical research, test development, and test improvement in peer-reviewed journals have been mainstays of R&D’s academic mission since the institute’s inception,” said Marc Elgort, PhD, codirector of ARUP’s Institute for Clinical and Experimental Pathology® (R&D).
“These activities drive conversations in many specialties across clinical diagnostic testing and support industries leading to continual improvement and refinement of testing and better patient care,” Elgort continued. “Our research activities have provided key insights allowing our medical directors to contribute to and drive changes in guidelines in clinical diagnostic testing, which again leads to improved patient outcomes.”
ARUP’s R&D Institute was created in 1996 to continually develop new tests, improve current tests, and review state-of-the-art laboratory diagnostic technologies. It operates alongside the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™, which was established in 2023 to drive innovation in laboratory medicine and enhance patient outcomes by bridging the gap between cutting-edge research and clinical application. The two institutes form a comprehensive, nonprofit research approach.
Learn more about ARUP’s scientific contributions through articles published to the ARUP Newsroom, free video lectures from the ARUP Institute for Learning, and episodes of the LabMind podcast hosted by Jonathan Genzen, MD, PhD, MBA, ARUP chief medical officer and senior director of governmental affairs.
Learn more about ARUP’s pTau 217 test here.
Bonnie Stray, bonnie.stray@aruplab.com
